Det er godt dokumentert at benzodiazepiner og benzodiazepinliknende sovemedisiner gir høy risiko for bivirkninger som fall, brudd, kognitiv svikt og delirium.
Redusere
Lukacisinová et al. The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different Europeon countries and Israel: retrospective results from the EU SHEL TER study. BMJ Geriatrics. (2021) 21:277
Nedtrapping
Det finnes ikke gode holdepunkter for at benzodiazepiner og benzodiazepinliknende sovemedisiner er nyttige for langtidsbehandling av søvnvansker.
Glass et al. Sedative hypnotics in older people with insomnio: meta-analysis of risks and benefits. BMJ. 2005:331(7526):1169
Avmedisinering
"Disse medisinene er risikable i bruk, og det finnes tryggere behandlingsalternativer. Vår forskning tyder på at vi trenger strategier for å redusere bruken av benzodiazepiner og benzodiazepinliknende sovemedisiner"
Olfson et al. Benzodiazepine Use in the United States. JAMA Psychiatry. 2014 Dec 17
Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedativehypnotic use to improve patient SAFEty and quality of care.
Oppdag essensen av vårt prosjekt i disse innsiktsfulle introduksjonsvideoene. Bli med oss på vår reise mot å utvikle beste praksis for å redusere bruken av sovemedisiner blant eldre voksne i Europa!
Fakta om benzodiazepiner og benzodiazepinliknende legemidler
Highlights
International Day of Older Persons 2026
On October 1st, 2026, BE-SAFE marked the International Day of Older Persons by highlighting the importance of healthy ageing, patient safety and quality of care as people live longer lives.
BE-SAFE and AGE Platform Europe raise awareness for World Patient Safety Day
In the 17th of September 2026, BE-SAFE marked World Patient Safety Day by highlighting the importance of good sleep and safer sleeping medicine use for older adults.
Read more BE-SAFE and AGE Platform Europe raise awareness for World Patient Safety Day
Benzodiazepines Awareness Day 2026
July 11th 2026 marks World Benzodiazepine Awareness Day, an international initiative dedicated...
Discover how it works: BE-SAFE talks - New video series introduces the project’s work packages
How does BE-SAFE bring together research, patient involvement and clinical practice? In June 2026, the project launched a new video series introducing its seven interconnected work packages and their contributions to safer sleeping medicine use among older adults.
World Health Day: Connecting science and clinical practice
On April 7th 2026, BE-SAFE marked World Health Day by highlighting the importance of connecting research with the needs of patients and healthcare professionals.
Read more World Health Day: Connecting science and clinical practice
Choosing Wisely Canada / Webinar: BE-SAFE - International Lessons on Safe Benzodiazepine Deprescribing
On the 28th of January 2026, BE-SAFE featured in a dedicated Choosing Wisely Canada webinar, bringing together research insights and practical perspectives on safer benzodiazepine deprescribing.
Scientific Publication Announcement
We are pleased to share that our study, Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe, has been published in Age and Ageing!
Scientific Publication Announcement
We are pleased to share that our study, Mapping care trajectories for hospital-initiated benzodiazepine deprescribing in older adults: a multicentre qualitative study, has been published in BMC Health Services Research!
BE-SAFE findings shared at the French geriatrics and gerontology meeting
How can healthcare professionals support safer benzodiazepine deprescribing in older adults? This question was explored by Prof. Anne Spinewine, BE-SAFE coordinator, during the annual meeting of the French Society of Geriatrics and Gerontology (SFGG), held in Paris on 24–26th November 2025...
Read more BE-SAFE findings shared at the French geriatrics and gerontology meeting
BE-SAFE clinical trial reaches 50% recruitment milestone
In November 2025, the BE-SAFE clinical trial reached an important milestone: 50% of its recruitment target, with more than 235 participants enrolled across Belgium, Greece, Norway, Poland, Spain and Switzerland...
Read more BE-SAFE clinical trial reaches 50% recruitment milestone
Scientific Publication Announcement
We are pleased to share that our study, Barriers to and Enablers of Supporting Deprescribing Benzodiazepines in Older Adults: A Survey of European Nonphysician Healthcare Professionals, has been published.
Scientific Publication Announcement
We are please to inform that our paper Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis has been published.
Human Rights Day
This week, in BE-SAFE, we celebrate International Human Rights Day...
International Care and Support day 2024
On International Care and support day BE-SAFE...
BE-SAFE consortium meeting 2024
BE-SAFE consortium successfully concludes 2024 Plenary Meeting in Barcelona, Spain
Open Webinar: Improving Diagnosis for Patient Safety
Join Us for an Open Webinar: Let's come together to discuss strategies for improving diagnosis and ensuring patient safety.
Read more Open Webinar: Improving Diagnosis for Patient Safety
Benzodiazepines Awareness Day
The BE-SAFE project has put together helpful resources to raise awareness about the risks of benzodiazepines. Click to learn more.
World Patient Safety Day
The BE-SAFE Project Commemorates World Days to Promote Healthy Sleep Practices with a gender perspective
Safer clinical practices
In a recent Lancet publication, European researchers unveil critical insights into insomnia treatment for older adults, shedding light on the vital role of deprescribing potentially harmful medications in older adults.
World Patient Safety Day
On September 17th, 2023, the world marks World Patient Safety Day under the theme "Engaging Patients for Patient Safety" with the slogan "Elevate the Voice of Patients!"
Benzodiazepine Awareness Day
On July 11, the world will unite to observe Benzodiazepine Awareness Day.
This event aims to raise awareness on the risk of the use of sleeping pills in older adults
World Sleep Day
March 17th is World Sleep Day! Do you want to know more about the importance of proper sleep? Take a look at our press release.
Introducing BE-SAFE international PAC members! What's the PAC? Find more about it in our press release!
Choosing Wisely Canada’s National Meeting
Choosing Wisely Canada’s National Meeting will return to an in-person event on May 11 and 12, 2023. Join us in Toronto at the Globe and Mail Centre for two days of engaging keynote speakers, workshops, and breakout sessions.
BE-SAFE kick-off meeting
The first BE-SAFE meeting took place in Brussels on September 14-15 2022.
During this meeting, project start and integration of the seven work packages have been discussed.
BE-SAFE project presented at Choosing Wisely annual meeting
BE-SAFE project presented at Choosing Wisely annual meeting in Lisbon: This year's Choosing Wisely International Roundtable, which aims to promote health decisions based on the best available scientific evidence, was held in Lisbon on September 21st and 22nd, 2022. During the meeting, our BE-SAFE project was introduced to the audience.
Read more BE-SAFE project presented at Choosing Wisely annual meeting
